Top Stories
L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM
Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM
Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM

Zydus gets USFDA approval for Levothyroxine Sodium for Injection
Zydus Lifesciences Limited on Tuesday has received final approval from the United States Food and Drug Administration (USFDA) for Levothyroxine Sodium for Injection 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial.
Levothyroxine Sodium Injection is indicated for the treatment of myxedema coma, the company informed to the stock exchange.
Further, the drug will be manufactured at the group’s injectable manufacturing facility at Jarod, near Vadodara (India).
The group now has 354 approvals and has so far filed over 440* ANDAs since the commencement of the filing process in FY 2003-04, the company said.
On Tuesday, at around 10:30 AM, Zydus Lifesciences was trading at Rs482.10 per share lower by 0.04% on the BSE.
Related News

L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM

NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr
4 mins read. August 2, 2024 at 12:33 PM
Download app
Access BlinkX
everywhere
across device
